Moreover, we provide data to show poor clinical outcomes in breast cancer patients with exceedingly high CD8+ TC/IM ratios, which were associated with increased frequencies of CD163+ and FoxP3+ cells. This evidence concerns the gene CD8A and breast carcinoma.